Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 10—October 2010


Effectiveness of Personal Protective Equipment and Oseltamivir Prophylaxis during Avian Influenza A (H7N7) Epidemic, the Netherlands, 2003

Dennis E. te BeestComments to Author , Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. Koopmans
Author affiliations: Author affiliations: Utrecht University, Utrecht, the Netherlands (D.E. te Beest, M.E.H. Bos, A. Stegeman); National Institute of Public Health and the Environment, Bilthoven, the Netherlands (D.E. te Beest, M. van Boven, M.P.G. Koopmans)

Main Article

Table 5

Comparison of conjunctivitis and serologic result case definitions for number of infections and prophylactic oseltamivir use during avian influenza A (H7N7) epidemic, the Netherlands, 2003*

Oseltamivir use

Serologic result
Not prescribed 6/35 9/63 12/16 22/26
Prescribed but not used during visit 12/45 25/80 26/34 48/64
Prescribed and used consistently 7/54 9/113 24/41 54/85
Prescribed and used inconsistently 5/26 13/65 11/18 24/39
Prescribed and consistency of use unknown 4/9 8/23 4/7 11/18
Prescribed but period of use unknown 9/47 15/109 17/30 40/68

*Data resulted from a survey conducted among poultry workers after the epidemic.
†No. persons infected/total no. persons.
‡No. visits by infected persons/total no. visits. Because visits were classified into groups, persons may be in 2 categories (prescribed not used and prescribed used).

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO